OMNICELL, INC.

Omnicell is a healthcare technology provider that focuses on autonomous medication management. The company aims to address challenges in medication management and support clinicians in healthcare. Omnicell helps customers develop cost-effective medication management strategies, enabling pharmacists and nurses to prioritize patient care over administrative tasks. This approach seeks to improve clinical, operational, and financial outcomes across various care settings. Omnicell's offerings include a medication management infrastructure with storage and dispensing automation, supported by an intelligence ecosystem. These solutions form the basis for customers to achieve the Autonomous Pharmacy, an industry vision aimed at improving operational efficiencies and targeting zero-error medication management, along with five other outcomes outlined in the Autonomous Pharmacy framework. In 2024, the United States spent $806 billion on prescription drugs, representing a 10.2% increase from 2023. The company identifies significant challenges in pharmacy practice, such as budget constraints and workforce shortages. Specifically, 88% of hospitals report technician deficits, and 92% lack sufficient sterile compounding expertise. Health systems also face increased liability from drug diversion, with a 61% increase in the average number of investigations per hospital since the beginning of 2023. Omnicell believes these challenges will drive demand for automation, visibility, insights, and improved medication management outcomes, which their solutions are designed to provide.